Structural and thermodynamic features which govern enzymatic nitric oxide detoxif
Structural and thermodynamic features which govern enzymatic nitric oxide detoxif
批准号:
8906891
负责人:
Ronald Koder
金额:
$29.66万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-15 至 2018-07-31
关键词:
Active SitesAffectAffinityAmyotrophic Lateral SclerosisBindingBiochemicalBlood SubstitutesCarrier ProteinsChemicalsChimera organismComplexCytochrome P450DioxygenasesDiseaseDistalDrug Metabolic DetoxicationElectron TransportElectronsElectrostaticsEnzymesEquilibriumFaceFlavinsFlavoproteinsFutureHealthHeart DiseasesHemeHeme IronHemoglobinHistidineHumanHuman BiologyIonsIschemic Brain InjuryLearningLeftLigand BindingLigandsLigationMalignant NeoplasmsMedicineMetabolicMethodsModificationMolecularNatureNitratesNitric OxideOxidesOxidoreductaseOxygenPathway interactionsPenetrationPlayPoisonPropertyProtein Binding DomainProtein DynamicsProteinsReactionRoleRotationScientistSideSiteStrokeStructureSurfaceTechnologyTertiary Protein StructureTestingTherapeuticThermodynamicsWaterWorkalpha helixbasecofactordesigndriving forceeffective therapyenzyme therapyinnovationmolecular dynamicsnext generationoxygen transportphthalate 4,5-dioxygenaseprotein structuresemiquinonesignal processingsynthetic enzymetherapeutic enzyme
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Significance. We aim to determine the essential structural and thermodynamic features which govern enzymatic nitric oxide detoxification. We use a cycle of computational design and biochemical analysis of an artificial nitric oxide dioxygenase (NOD) formed by combining an artificial heme-based oxygen binding protein domain with a flavoprotein reductase domain derived from nature. Use of such a robust, simple protein makes it significantly easier to make both small- and large-scale changes to the protein and positively identify critical features necessary for enzyme function. Nitric oxide plays a central role in many signaling process in human biology, yet due to its degree of chemical reactivity it has also been implicated in a surprising number of serious disorders such as Lou Gehrig's Disease and ischemic brain injury. A superior nitric oxide dioxygenase thus promises to be useful in future treatments of many pathological conditions. Conversely, unwanted NOD activity has produced severe complications in hemoglobin-based blood substitutes, and it is important to learn how to reduce or eliminate NOD activity in these therapeutics without adversely affecting oxygen binding. Innovation. This catalytic construct represents the next generation in protein design, moving design technology from the current focus on simple protein domains with single cofactors to significantly more challenging and sophisticated multidomain structures that more closely resemble the complex assemblies seen in nature. This project has the capacity to dramatically advance two important technologies: hemoglobin-based blood substitutes and enzyme therapeutics. First, lessons learned in this project promise to revitalize the field of hemoglobin-based blood substitutes, enabling both the reengineering of native hemoglobins and the creation of entirely new oxygen transport proteins minimally reactive with nitric oxide while still carrying oxygen. Second, a synthetic enzyme has the potential to transform the field of enzyme therapy because of the many advantages designed enzymes have over their natural counterparts, most importantly the ability to utilize non-natural cofactors
better optimized for the target activity and their greatly increased stability over natural protein (53). This project thus represents a new direction in enzyme therapy, and our design pathway is an enabling technology which will be used by us and others in the creation of future enzyme therapeutics. Specific Aims. This work will allow us to answer some important questions about this enzyme: Aim 1. What role does the heme reduction potential play in the nitric oxide dioxygenase reaction? Aim 2. How important are electron transfer dynamics and thermodynamics in this reaction? Aim 3. How do protein dynamics and structure govern NOD function?
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structural and thermodynamic features which govern enzymatic nitric oxide detoxif
-
批准号:9119027
-
项目类别:
-
资助金额:$29.83万
-
财政年份:2014
-
负责人:Ronald Koder
-
依托单位:
Minority Supplement for GM111932
-
批准号:9282901
-
项目类别:
-
资助金额:$9.14万
-
财政年份:2014
-
负责人:Ronald Koder
-
依托单位:
Structural and thermodynamic features which govern enzymatic nitric oxide detoxif
-
批准号:8767796
-
项目类别:
-
资助金额:$27.23万
-
财政年份:2014
-
负责人:Ronald Koder
-
依托单位:
De novo Designed Safranine Enzymes for Cancer Therapy (pilot)
-
批准号:7231600
-
项目类别:
-
资助金额:$7.49万
-
财政年份:2007
-
负责人:Ronald Koder
-
依托单位:
Model Protein Studies of Flavin Redox Potential Tuning
-
批准号:6611039
-
项目类别:
-
资助金额:$1.34万
-
财政年份:2002
-
负责人:Ronald Koder
-
依托单位:
Model Protein Studies of Flavin Redox Potential Tuning
-
批准号:6525397
-
项目类别:
-
资助金额:$4.42万
-
财政年份:2002
-
负责人:Ronald Koder
-
依托单位:
Model Protein Studies of Flavin Redox Potential Tuning
-
批准号:6406115
-
项目类别:
-
资助金额:$3.48万
-
财政年份:2001
-
负责人:Ronald Koder
-
依托单位:
De novo Designed Safranine Enzymes for Cancer Therapy (pilot)
-
批准号:7574572
-
项目类别:
-
资助金额:$7.9万
-
财政年份:--
-
负责人:Ronald Koder
-
依托单位:
De novo Designed Safranine Enzymes for Cancer Therapy (pilot)
-
批准号:8035946
-
项目类别:
-
资助金额:$7.39万
-
财政年份:--
-
负责人:Ronald Koder
-
依托单位:
De novo Designed Safranine Enzymes for Cancer Therapy (pilot)
-
批准号:7762776
-
项目类别:
-
资助金额:$7.9万
-
财政年份:--
-
负责人:Ronald Koder
-
依托单位:
海外基金